Cargando…
Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways
Metabolic syndrome (MetS) and ovarian hormone deficiency could affect bladder storage dysfunction. Epigallocatechin-3-gallate (EGCG), a polyphenolic compound in green tea, has been shown to protect against ovarian hormone deficiency induced overactive bladder (OAB). The present study investigated ox...
Autores principales: | Lee, Yi-Lun, Lin, Kun-Ling, Wu, Bin-Nan, Chuang, Shu-Mien, Wu, Wen-Jeng, Lee, Yung-Chin, Ho, Wan-Ting, Juan, Yung-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876359/ https://www.ncbi.nlm.nih.gov/pubmed/29599473 http://dx.doi.org/10.1038/s41598-018-23800-w |
Ejemplares similares
-
Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial
por: Lin, Kun-Ling, et al.
Publicado: (2021) -
Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome
por: Lu, Jian-He, et al.
Publicado: (2021) -
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study
por: Lee, Yung-Chin, et al.
Publicado: (2020) -
In Vitro Toxicity of Epigallocatechin Gallate in Rat Liver Mitochondria and Hepatocytes
por: Kucera, Otto, et al.
Publicado: (2015) -
Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches
por: Lee, Hsiang-Ying, et al.
Publicado: (2019)